- Works to prevent persistent viremia when cats have been exposed to virulent feline leukemia virus
- Helps prevent diseases and lymphoid tumors caused by FeLV infection
- Vaccinates healthy cats to prevent diseases associated with chlamydia psittaci, panleukopenia and calicivirus, and feline rhinotracheitis
- Ideal for frequently-boarded, indoor, or outdoor cats
- Works beyond core antigen protection to provide feline chlamydophila felis and FeLV infections
- The only vaccine that is proven to be effective long-term in studies based on real-life conditions
- The only USDA-licensed vaccine with 2 years of immunity against FeLV
- Superior efficacy compared to multiple vaccines for FeLV
- The only vaccine proven to prevent persistent viremia for a 2-year period
- Blocks canine parvovirus replication
MODIFIED LIVE VIRUS AND CHLAMYDIA AND KILLED VIRUS
- Never mix with another product unless the label expressly recommends it.
- New, non-chemically sterilized should be used with each vaccine.
- Unused contents should be inactivated before disposing. To dispose, container and any unused contents should be burned.
- If human exposure occurs, seek medical attention.
- Do not use in pregnant cats.
- Amphotericin B and gentamicin are included as preservatives.
- Allergic or inflammatory reactions may occur. An antidote of antihistamines, corticosteroids, and/or epinephrine may all be required, based on the severity and nature of the cat's reaction.
- Injection site fibrosarcomas are known to develop with the use of some veterinary biologicals.
Transfer contents of the Fevaxyn FeLV vial to the
Eclipse 4 vial aseptically. Mix gently until dissolved. Use entire contents
immediately after rehydration.
Two doses are required for primary
immunization.
Initial vaccination: Inject 1 dose (1 mL)
subcutaneously or intramuscularly at 9 weeks of age or older.
Second vaccination: Inject 1 dose (1 mL)
subcutaneously or intramuscularly 3 to 4 weeks following the initial
vaccination.
MODIFIED LIVE VIRUS AND CHLAMYDIA AND KILLED VIRUS